Erythropoietin: Can we afford to use it? Can we afford not to?

Transfusion Medicine

Volumn 16, Issue 3, 2006, Pages 204-205

  Laird, J ^a  

^a SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

Anaemia; Blood transfusion; Cancer; Erythropoietin; Quality of life

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; DRUG COST; ECONOMIC ASPECT; ERYTHROCYTE; EVALUATION; HUMAN; RISK ASSESSMENT; UNITED KINGDOM;

ANEMIA; COST-BENEFIT ANALYSIS; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN; HUMANS; NEOPLASMS;

EID: 33744906530     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2006.00670.x     Document Type: Article

References (10)

1. Barosi G. Marchetti M. Liberate N.L. 1998 Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia. British Journal of Cancer, 78, 781 787.
2. Bohlius J. Langensiepen S. Schwarzer G. Seidenfeld J. Piper M. Engert A. 2005 Erythropoietin for patients with malignant disease. The Cochrane Database of Systematic Reviews (Issue 4). Article No: 00003407, doi: 10.1002/14651858. CD003407.pub3.
3. Cella D. Lai J.-S. Chang C.H. Peterman A. Slavin M. 2002 Fatigue in cancer patients compared with fatigue in the general United States population. Cancer, 94, 528 538.
4. Franklin I.M. 1999 The impact on British blood services on BSE and V-CJD: implications for patients, donors and public health. Scottish Medical Journal, 44, 35 36.
5. Henke M. Laszig R. Rube C. Schafer U. Haase K.D. Schilcher B. Mose S. Beer K.T. Burger U. Dougherty C. Frommhold H. 2003 Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet, 362, 1255 1260.
6. Jones M. Schenkel B. Just J. Fallowfield L. 2004 Epoetin alpha improves quality of life in patients with cancer, results of metaanalysis. Cancer, 101, 1720 1732.
7. Ludwig H. Van Belle S. Barrett-Lee P. Birgegard G. Bokemeyer C. Gascon P. Kosmidis P. Krzakowski M. Nortier J. Olmi P. Schneider M. Schrivers D. 2004 The European Cancer Anaemia Survey (ECAS), a large, multinational, prospective survey defining the prevalence, incidence and treatment of anaemia in cancer patients. European Journal of Cancer, 40, 2293 2306.
8. Mano M. Mutzberger P. Reid A. Rodger A. Soutar R. Welsh J. 2005 Current role of erythropoietin in the management of patients with haematological and solid malignancies. Cancer Therapy, 3, 41 56.
9. McClelland D.B. Contreras M. 2005 Appropriateness and safety of blood transfusion. British Medical Journal, 330, 104 105.
10. Wisloff F. Smith A. 2005) The quality of life benefit associated with epoetin treatment in multiple myeloma and lymphoma is small. Proceedings of the 10th International Workshop on Multiple Myeloma, Sydney.